Dr. Sue S. Yom
Claim this profileUniversity of California, San Francisco
Studies Cancer
Studies Head and Neck Cancers
9 reported clinical trials
18 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Head And Neck Cancers
p16 negative
EGFR positive
EGFR negative
Affiliated Hospitals
Clinical Trials Sue S. Yom is currently running
SBRT
for Adenoid Cystic Carcinoma
The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of the study intervention involved in this study is: * Stereotactic Body Radiation Therapy (SBRT)
Recruiting1 award N/A13 criteria
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
More about Sue S. Yom
Clinical Trial Related1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sue S. Yom has experience with
- Cisplatin
- Nivolumab
- Intensity-Modulated Radiation Therapy
- Cetuximab
- Ipilimumab
- Durvalumab
Breakdown of trials Sue S. Yom has run
Cancer
Head and Neck Cancers
Nasopharyngeal Carcinoma
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sue S. Yom specialize in?
Sue S. Yom focuses on Cancer and Head and Neck Cancers. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sue S. Yom currently recruiting for clinical trials?
Yes, Sue S. Yom is currently recruiting for 4 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Sue S. Yom has studied deeply?
Yes, Sue S. Yom has studied treatments such as Cisplatin, Nivolumab, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Sue S. Yom?
Apply for one of the trials that Sue S. Yom is conducting.
What is the office address of Sue S. Yom?
The office of Sue S. Yom is located at: University of California, San Francisco, San Francisco, California 94158 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.